维普中文期刊产品整合服务
10篇 您的检索式:作者名="Daholf B"
    题名 作者 年代 出处 被引量
1Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study(LIFE):a randomized trial against atenolol显示文摘Daholf B Devereux RB Kjeldsen SE 2002Lancet2002,359,:1
2Role of blood pressure and other variables in the differential cardiovascular event rates noted in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm(ASCOTBPLA)显示文摘Poulter NR Wedel H Daholf B 2005Lancet2005,366,:1
3Cardiovascular morbidity and mortality in the losartan intervention for endpoint reduction in hypertension study(LIFE):a randomised trial against atenolol显示文摘Daholf B Devereux RB Kjeldsen SE 2002Lancet2002,359,9311:1
4Left ventricular hypertrophy and angiotension Ⅱ antagonist 显示文摘Daholf B 2001Am J Hypertens2001,14,2:1
5Prevention of cardiovascular events with an antihypertensive regimen of amlodipine adding perindopril as required versus atenolol adding bendroflumethiazide as required,in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm(ASCOT-BPLA):a multicentre randomized controlled trial显示文摘Daholf B Sever P Poulter NR 2005Lancet2005,366,9489:1
6Cardiovascular morbidity and mortality inpatient with diabetes in the losartan intervention for endpoitnt reduction in hypertension study(LIFE) 显示文摘Lindholm LH Bsen H Daholf B 2002Lancet2002,359,9311:1
7Prevention of coronary and stroke events with atorvastatoin in hypertention patients who have anerage or lower 2 than average cholesterol concentrations in the Anglo-Scanolinavian Cardiac Outcomes Trial-lipid Lowering Arm(ASCOT-LLA):a ulticentre randomized controlled trial显示文摘Sever PS Daholf B Pouter NF 2003Lancet2003,361,9364:1
8Cardio - Vascular morbidity and mortality in the losartan Intervention for Endpoint reduction in hypertension study(LIFE):a randomized trial against atenolol显示文摘Daholf B Devereux R Kjeldsen S 2004Lancet2004,359,9311:1
9Prevention of cardiovascular events with an antihypertensive regimen of amlodipine adding perindopril as required versus atenolol adding bendroflumethiazide as required,in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm(ASCOT-BPLA): a multicentre randomized controlled trial显示文摘Daholf B Sever P Poulter NR 2005Lancet2005,366,9489:1
10Cardiovascular morbidity and mortality inpatient with diabetes in the losartan intervention for endpoint reduction in hypertension study(LIFE)显示文摘LINDHOLM L H IBSEN H DAHOLF B 2002Lancet2002,359,9311:1
返回顶部 每页显示:
共1页 首页 上一页 第1页 下一页 末页 /1 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费